|
Current issue
Archive
Online First
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
|
2/2003
vol. 2 abstract:
Causes of bleeding in HRT users and non user postmenopausal women
Barbara Grzechocińska
,
Halina Gadomska
,
Longin Marianowski
,
Tomasz Dworniak
(Prz Menopauz 2003, 2: 42–45)
Online publish date: 2003/04/11
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Introduction: Only 6% of postmenopausal women use HRT in Poland. In most cases the reason for discontinuation of HRT is the occurrence of unexpected bleeding and fear of the risk of the malignant disease as a result of the hormonal treatment. The aim of the study was to investigate the main causes of uterine bleeding in HRT users.
Materials and Methods: Pathological findings from 134 postmenopausal patients with uterine bleeding were analyzed. 67 of them were using HRT. The control group consisted of 67 postmenopausal women without HRT. All bleeding women underwent medical examination; the cervical and endocervical assessment as well as uterine curettage was performed. Results: The relative risk (RR) of all abnormal results of pathological findings: endometrial cancer, cervical cancer, endometrial hyperplasia with atypia was 2.71 (95% confidence interval 1.44–3.97) in the group of women without HRT. The odds ratio (OR) of stadium secretionis endometrii, atrophia endometrii in HRT users were respectively 4.65 (95% confidence interval 0–10.77) and 2.47 (95% confidence interval 0.07–4.87). Conclusions: 1. HRT does not increase the risk of endometrial hyperplasia, particularly those complicated by atypia and uterine neoplasia. 2. Atrophic endometrial findings are more frequent in the group of HRT women. keywords:
menopause, hormonal replacement therapy, endometrial cancer |